Skip to main content

Table 3 Median VEGF superfamily expression in people with and without metabolic syndrome or its components

From: Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis

 

Gene

Disease group (pg/ml)

Control group (pg/ml)

Ratio

Metabolic syndrome

 Doupis 2011/2 [50]

VEGF-A

139

88

1.58

 Jesmin 2013 [25]

VEGF-A

483.93

386.88

1.25

 Lim 2004/1 [28]

VEGF-A

200

90

2.22

 Lim 2004/2 [28]

VEGF-A

180

90

2.00

 Litvinova 2014 [29]

VEGF-A

180

172

1.05

 Mirhafez 2015 [34]

VEGF-A

38.55

82.18

0.47

 Mirhafez 2016 [35]

VEGF-A

85.5

81.1

1.05

 Siervo 2010 [42]

VEGF-A

431.8

350.6

1.23

 Siervo 2010 [42]

PIGF

13.5

11.5

1.17

 Wada 2010 [47]

VEGF-A

332.3

268.8

1.24

Hyperglyecmia

 Doupis 2011/1 [50]

VEGF-A

165

88

1.88

 Doupis 2011/2 [50]

VEGF-A

139

88

1.58

 Guo 2014 [22]

VEGF-A

269.41

211.36

1.27

 Jesmin 2013 [25]

VEGF-A

483.93

386.88

1.25

 Kubisz 2010 [27]

VEGF-A

338.5

182

1.86

 Lim 2004/1 [28]

VEGF-A

200

90

2.22

 Lim 2004/2 [28]

VEGF-A

180

90

2.00

 Mahdy 2011 [32]

VEGF-A

16.25

6.35

2.56

 Marek 2010 [33]

VEGF-A

117.43

113.03

1.04

 Mirhafez 2015 [34]

VEGF-A

38.55

82.18

0.47

 Mirhafez 2016 [35]

VEGF-A

85.5

81.1

1.05

 Mysliwiec 2008 [36]

VEGF-A

172

93.66

1.84

 Ruszkowska-Ciastek 2014 [39]

VEGF-A

11.15

12.13

0.92

Obesity

 Doupis 2011/1 [50]

VEGF-A

139

88

1.58

 Doupis 2011/2 [50]

VEGF-A

239

88

2.72

 Litvinova 2014 [29]

VEGF-A

180

172

1.05

 Mirhafez 2015 [34]

VEGF-A

38.55

82.18

0.47

 Mirhafez 2016 [35]

VEGF-A

85.5

81.1

1.05

 Ruszkowska-Ciastek 2014 [39]

VEGF-A

11.15

12.13

0.92

 Siervo 2010 [42]

VEGF-A

431.8

350.6

1.23

 Siervo 2010 [42]

PIGF

13.5

11.5

1.17

 Siervo 2012 [43]

VEGF-A

341

264

1.29

 Siervo 2012 [43]

PIGF

14

12.2

1.15

Hypertension

 Doupis 2011/1 [50]

VEGF-A

139

88

1.58

 Doupis 2011/2 [50]

VEGF-A

239

88

2.72

 Guo 2014 [50]

VEGF-A

269.41

211.36

1.27

 Lim 2004/1 [28]

VEGF-A

200

90

2.22

 Lim 2004/2 [28]

VEGF-A

180

90

2.00

 Mahdy 2011 [32]

VEGF-A

16.25

6.35

2.56

 Mirhafez 2015 [34]

VEGF-A

38.55

82.18

0.47

 Ruszkowska-Ciastek 2014 [39]

VEGF-A

11.15

12.13

0.92

 Siervo 2010 [42]

VEGF-A

431.8

350.6

1.23

 Siervo 2010 [42]

PIGF

13.5

11.5

1.17

 Valabhji 2001 [46]

VEGF-A

217

137

1.58

 Wada 2010 [47]

VEGF-A

332.3

268.8

1.24

Low HDL

 Jesmin 2013 [25]

VEGF-A

483.93

386.88

1.25

 Mirhafez 2016 [35]

VEGF-A

85.5

81.1

1.05

High triglycerides

 Doupis 2011/2 [50]

VEGF-A

139

88

1.58

 Jesmin 2013 [25]

VEGF-A

483.93

386.88

1.25

 Lim 2004/1 [28]

VEGF-A

200

90

2.22

 Lim 2004/2 [28]

VEGF-A

180

90

2.00

 Mirhafez 2016 [35]

VEGF-A

85.5

81.1

1.05

 Siervo 2010 [42]

VEGF-A

431.8

350.6

1.23

 Siervo 2010 [42]

PIGF

13.5

11.5

1.17

 Wada 2010 [47]

VEGF-A

332.3

268.8

1.24

High LDL

 Lim 2004/1 [28]

VEGF-A

200

90

2.22

 Lim 2004/2 [28]

VEGF-A

180

90

2.00

 Wada 2010 [47]

VEGF-A

332.3

268.8

1.24

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us